Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1958 1
1960 1
1961 3
1962 1
1963 3
1964 3
1965 1
1966 5
1967 4
1968 2
1969 1
1970 9
1971 9
1972 6
1973 3
1974 4
1975 7
1976 17
1977 31
1978 26
1979 30
1980 25
1981 28
1982 38
1983 29
1984 49
1985 47
1986 43
1987 41
1988 50
1989 41
1990 44
1991 63
1992 68
1993 65
1994 59
1995 65
1996 55
1997 72
1998 93
1999 105
2000 139
2001 94
2002 91
2003 112
2004 106
2005 145
2006 137
2007 129
2008 127
2009 147
2010 164
2011 171
2012 184
2013 171
2014 175
2015 184
2016 170
2017 161
2018 180
2019 148
2020 138
2021 128
2022 103
2023 101
2024 108
2025 130
2026 84

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,514 results

Results by year

Filters applied: . Clear all
Page 1
Drug-induced parkinsonism: diagnosis and treatment.
Conn H, Jankovic J. Conn H, et al. Expert Opin Drug Saf. 2024 Dec;23(12):1503-1513. doi: 10.1080/14740338.2024.2418950. Epub 2024 Oct 25. Expert Opin Drug Saf. 2024. PMID: 39419777 Review.
INTRODUCTION: Drug-induced parkinsonism (DIP) is one of the most common iatrogenic movement disorders. It is characterized by tremors, slowness of movement, and shuffling gait with postural instability, clinically indistinguishable from idiopathic P …
INTRODUCTION: Drug-induced parkinsonism (DIP) is one of the most common iatrogenic movement disorders. It is cha …
[Drug-induced Parkinsonism as Viewed from Neurologist].
Tomiyama M. Tomiyama M. Brain Nerve. 2025 Jun;77(6):715-719. doi: 10.11477/mf.188160960770060715. Brain Nerve. 2025. PMID: 40518581 Review. Japanese.
Drug-induced Parkinsonism (DIP) is a common iatrogenic movement disorder. Its clinical manifestations cannot be distinguished from those of idiopathic Parkinson's disease. ...Clinicians must always suspect DIP when a patient develops suba …
Drug-induced Parkinsonism (DIP) is a common iatrogenic movement disorder. Its clinical manifestations cannot be disting …
The diagnosis of Parkinson's disease.
Tolosa E, Wenning G, Poewe W. Tolosa E, et al. Lancet Neurol. 2006 Jan;5(1):75-86. doi: 10.1016/S1474-4422(05)70285-4. Lancet Neurol. 2006. PMID: 16361025 Review.
The correct diagnosis of Parkinson's disease is important for prognostic and therapeutic reasons and is essential for clinical research. Investigations of the diagnostic accuracy for the disease and other forms of parkinsonism in community-based …
The correct diagnosis of Parkinson's disease is important for prognostic and therapeutic reasons and is essential for c …
DAT imaging in drug-induced and psychogenic parkinsonism.
Tolosa E, Coelho M, Gallardo M. Tolosa E, et al. Mov Disord. 2003 Oct;18 Suppl 7:S28-33. doi: 10.1002/mds.10575. Mov Disord. 2003. PMID: 14531043 Review.
Parkinson's syndrome (PS) is frequently encountered in disorders associated with prominent degeneration of the nigrostriatal pathway as in Parkinson's disease, multisystem atrophy, and progressive supranuclear palsy (presynaptic PS). D …
Parkinson's syndrome (PS) is frequently encountered in disorders associated with prominent degeneration of the nigrostr …
The treatment of Parkinson's disease.
Godwin-Austen RB. Godwin-Austen RB. Postgrad Med J. 1977 Dec;53(626):729-31. doi: 10.1136/pgmj.53.626.729. Postgrad Med J. 1977. PMID: 343079 Free PMC article. Review.
The treatment of Parkinson's disease is discussed. Levodopa is the most effective drug in this therapy. The place of other agents is discussed....
The treatment of Parkinson's disease is discussed. Levodopa is the most effective drug in this therapy. The place of ot …
Amantadine in the treatment of Parkinson's disease and other movement disorders.
Rascol O, Fabbri M, Poewe W. Rascol O, et al. Lancet Neurol. 2021 Dec;20(12):1048-1056. doi: 10.1016/S1474-4422(21)00249-0. Epub 2021 Oct 19. Lancet Neurol. 2021. PMID: 34678171 Review.
Other uses of amantadine, such as in the treatment of drug-induced parkinsonism, atypical parkinsonism, Huntington's disease, or tardive dyskinesia, lack a strong evidence base. Future trials should examine its role in the management of motor an …
Other uses of amantadine, such as in the treatment of drug-induced parkinsonism, atypical parkinsonism, Huntingt …
Drug-induced Parkinsonism: A strong predictor of idiopathic Parkinson's disease.
Jeong S, Cho H, Kim YJ, Ma HI, Jang S. Jeong S, et al. PLoS One. 2021 Mar 1;16(3):e0247354. doi: 10.1371/journal.pone.0247354. eCollection 2021. PLoS One. 2021. PMID: 33647030 Free PMC article.
BACKGROUND: Although Idiopathic Parkinson's disease (IPD) develops in considerable patients with drug-induced Parkinsonism (DIP), the association hasn't been well defined. ...
BACKGROUND: Although Idiopathic Parkinson's disease (IPD) develops in considerable patients with drug-induced …
Decreased thalamic monoamine availability in drug-induced parkinsonism.
Oh YS, Yoo SW, Lyoo CH, Kim JS. Oh YS, et al. Sci Rep. 2022 Mar 8;12(1):3749. doi: 10.1038/s41598-022-07773-5. Sci Rep. 2022. PMID: 35260679 Free PMC article.
Drug-induced parkinsonism (DIP) is caused by a dopamine receptor blockade and is a major cause of misleading diagnosis of Parkinson's disease (PD). ...The groups were evenly matched for age, but there were numerically more females in the …
Drug-induced parkinsonism (DIP) is caused by a dopamine receptor blockade and is a major cause of misleading diagnosis …
Clinical MRI Biomarkers to Differentiate Parkinson Disease from Its Mimics.
Haller S, He N, Schwarz S, Haacke EM. Haller S, et al. Radiology. 2025 Oct;317(1):e242044. doi: 10.1148/radiol.242044. Radiology. 2025. PMID: 41085393 Review.
The clinical discrimination of Parkinson disease (PD) from its mimics can be challenging, especially in the early stages. These mimics include atypical parkinsonian syndromes (APSs), essential tremor, drug-induced parkinsonism, and vascul …
The clinical discrimination of Parkinson disease (PD) from its mimics can be challenging, especially in the early stages. Thes …
4,514 results